CH211204A - Process for making a suppository base. - Google Patents

Process for making a suppository base.

Info

Publication number
CH211204A
CH211204A CH211204DA CH211204A CH 211204 A CH211204 A CH 211204A CH 211204D A CH211204D A CH 211204DA CH 211204 A CH211204 A CH 211204A
Authority
CH
Switzerland
Prior art keywords
parts
suppository base
making
bile
absorption
Prior art date
Application number
Other languages
German (de)
Inventor
Gesellschaft Fuer Chemis Basel
Original Assignee
Chem Ind Basel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Ind Basel filed Critical Chem Ind Basel
Publication of CH211204A publication Critical patent/CH211204A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)

Description

  

  
 



  Verfahren zur Herstellung einer Suppositoriengrundmasse.



   Die rektale Verabreichung von lleilmitteln bietet gegenüber der parenteralen Applikation in vielen Fällen grosse Vorteile. Sie stösst aber oft auf Schwierigkeiten, da viele Stoffe vom Rektum oder von der Vagina aus nicht oder ungenügend resorbiert werden und daher keine   Wirkung    entfalten können.



   Es wurde nun gefunden, dass man die Resorption dieser Stoffe vom Darm oder von der Vagina aus ermöglichen oder wesentlich steigern kann, wenn man der Suppositoriengrundmasse gallensaure Salze zusetzt. Selbstverständlich kann man auch Galle selbst hinzufügen, da diese gallensaure Salze enthält. Gallensäuren und Galle wirken in grö sserer Menge abführend. Überraschenderweise genügen aber für die Resorption schon Mengen, die diese Wirkung nicht hervorrufen.



  Es ist bekannt, dass Gallensäuren eine wichtige Rolle bei der Fettresorption spielen. Die Tatsache aber, dass die Gallensäuren die Resorption auch von zum Beispiel an sich wasserlöslichen und dennoch unresorbierbaren Stoffen bewirken können, ist völlig neu und bedeutet einen neuen Fortschritt für die Therapie.



   Die Anwendung der neuen Suppositoriengrundmasse gibt erstmals die   Möglichkeit,    wie viele Versuche an Tieren und am Men  schen    zeigten, z. B. lösliche Quecksilberkom  plexverbindungen    und auch Hormone rektal oder vaginal zur Wirkung zu bringen. Queck  silberkouiplexverbindungen    werden sonst rektal oder vaginal nicht resorbiert oder aber die Reaktion muss zur Resorption so stark alkalisch gehalten werden, dass die Schleimhaut des Rektums oder der Vagina zu sehr angegriffen wird. Dank dem Zusatz von zum Beispiel einer kleinen Menge desoxycholsaurem Natrium kann man Suppositorien mit einem Quecksilberdiureticum herstellen, die bei neutraler Reaktion ausgezeichnete Wirkung entfalten.

   Sogar Insulin mit einer dem Einweiss nahekommenden   Molekelgrösse    kann mittels der neuartigen Suppositoriengrundmasse. zur Resorption gebracht werden,  wobei die langsamere Resorption im Vergleich zu der bei subkutaner Injektion therapeutisch nur erwünscht ist.



   Die neuartige Suppositoriengrundmasse kann insbesondere auch vorteilhaft mit solchen Arzneimitteln verarbeitet   werden,    die an sich wasserlöslich sind, aber dennoch nicht oder nur   schmier    resorbiert werden.



   Beispiel 1:
100 g Cacaobutter werden unter Zusatz von 10 g Wachs geschmolzen. In die Schmelze trägt man 3 Teile cholsaures Natrium ein.



   Beispiel 2:
In 100 Teile geschmolzene Cacaobutter wird 1 Teil desoxycholsaures Natrium eingetragen.



   Beispiel 3:
100 Teile geschmolzene   Caeaobutter    werden mit 3 Teilen gereinigter Galle unter Rühren zu einer homogenen Mischung verarbeitet.



   Beispiel 4:
100 Teile Cacaobutter werden unter Zusatz von 5 Teilen Wachs geschmolzen und mit einer Mischung von je 2 Teilen tauro  cholsaurcm    und glykocholsaurem Natrium versetzt.



   Beispiel 5:
100 Teile geschmolzene Cacaobutter werden mit 4 Teilen ungereinigter Galle unter Verwendung eines Emulgators und unter Riihren homogenisiert.



   Beispiel 6:
12,5 Teile Gelatine, 25 Teile Wasser, 61,5 Teile Glyzerin und 1 Teil desoxycholsaures Natrium werden vermischt.   



  
 



  Process for making a suppository base.



   The rectal administration of oils offers great advantages over parenteral administration in many cases. However, it often encounters difficulties, since many substances are not or insufficiently absorbed from the rectum or vagina and therefore cannot develop any effect.



   It has now been found that the absorption of these substances from the intestine or the vagina can be made possible or significantly increased by adding bile acid salts to the suppository base. Of course, you can also add bile yourself, as it contains bile-acid salts. Bile acids and bile have a laxative effect in larger quantities. Surprisingly, however, quantities that do not produce this effect are sufficient for absorption.



  It is known that bile acids play an important role in fat absorption. The fact, however, that the bile acids can also effect the absorption of, for example, water-soluble and non-absorbable substances, is completely new and represents a new advance in therapy.



   The application of the new suppository base material gives the first time the possibility, as many tests on animals and people showed, z. B. to bring soluble Mercury Complex compounds and hormones rectally or vaginally to effect. Mercury complex compounds are otherwise not absorbed rectally or vaginally, or the reaction must be kept so strongly alkaline for absorption that the mucous membrane of the rectum or vagina is attacked too much. Thanks to the addition of, for example, a small amount of sodium deoxycholic acid, suppositories can be made with a mercury diuretic, which have an excellent effect in a neutral reaction.

   Even insulin with a molecule size that comes close to protein can be used with the new suppository base. be brought to absorption, the slower absorption compared to that with subcutaneous injection is only therapeutically desirable.



   The novel suppository base can, in particular, also advantageously be processed with drugs that are inherently water-soluble, but are nevertheless not or only poorly resorbed.



   Example 1:
100 g cocoa butter are melted with the addition of 10 g wax. 3 parts of sodium cholate are introduced into the melt.



   Example 2:
1 part of sodium deoxycholate is added to 100 parts of melted cocoa butter.



   Example 3:
100 parts of melted Caeao butter are mixed with 3 parts of purified bile while stirring to form a homogeneous mixture.



   Example 4:
100 parts of cocoa butter are melted with the addition of 5 parts of wax and mixed with a mixture of 2 parts each of taurocholic acid and sodium glycolate.



   Example 5:
100 parts of melted cocoa butter are homogenized with 4 parts of unpurified bile using an emulsifier and while stirring.



   Example 6:
12.5 parts of gelatin, 25 parts of water, 61.5 parts of glycerol and 1 part of sodium deoxycholic acid are mixed.

 

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung einer Suppo sitoriengrundmasse, dadurch gekennzeichnet, dass man dem leichtschmelzbaren indifferenten Grundstoff gallensaure Salze in geringer Menge zusetzt. PATENT CLAIM: Process for the production of a suppository base, characterized in that small amounts of bile acid salts are added to the easily meltable, inert base material.
CH211204D 1938-12-13 1938-12-13 Process for making a suppository base. CH211204A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH211204T 1938-12-13

Publications (1)

Publication Number Publication Date
CH211204A true CH211204A (en) 1940-08-31

Family

ID=4447232

Family Applications (1)

Application Number Title Priority Date Filing Date
CH211204D CH211204A (en) 1938-12-13 1938-12-13 Process for making a suppository base.

Country Status (1)

Country Link
CH (1) CH211204A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2371926A1 (en) * 1975-09-30 1978-06-23 Yamanouchi Pharma Co Ltd Rectal insulin hypoglycaemic compsn. - contg. surfactant or bile acid (salt) as absorption accelerator
FR2381520A1 (en) * 1977-02-28 1978-09-22 Yamanouchi Pharma Co Ltd COMPOSITIONS FOR RECTAL USE
FR2620331A1 (en) * 1987-09-15 1989-03-17 Sandoz Sa SUPPOSITORIES BASED ON CALCITONIN
GR880100604A (en) * 1988-09-14 1994-03-31 Sandoz Ag Improvements in or relating to calcitonins

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2371926A1 (en) * 1975-09-30 1978-06-23 Yamanouchi Pharma Co Ltd Rectal insulin hypoglycaemic compsn. - contg. surfactant or bile acid (salt) as absorption accelerator
FR2381520A1 (en) * 1977-02-28 1978-09-22 Yamanouchi Pharma Co Ltd COMPOSITIONS FOR RECTAL USE
FR2620331A1 (en) * 1987-09-15 1989-03-17 Sandoz Sa SUPPOSITORIES BASED ON CALCITONIN
BE1001937A3 (en) * 1987-09-15 1990-04-17 Sandoz Sa Suppository based calcitonin.
GR880100604A (en) * 1988-09-14 1994-03-31 Sandoz Ag Improvements in or relating to calcitonins

Similar Documents

Publication Publication Date Title
CH211204A (en) Process for making a suppository base.
DE630608C (en) Process for the production of a water-soluble, easily absorbable and diffusible base material for suppositories
DE479229C (en) Process for the production of copper, zinc and magnesium salts of tannin
DE862044C (en) Process for the production of dry preparations for the preparation of ointment bases or ointments
DE707580C (en) Process for the preparation of emulsions containing therapeutically active substances for injection purposes
DE556716C (en) Process for the production of stable colloidal aqueous solutions of the irradiated ergosterol
AT124884B (en) Process for the production of hormone preparations.
DE704550C (en) Process for the preparation of water- or lipoid-soluble salts of locally anesthetically effective, optionally amino-substituted benzoic acid alkyl or. -alkamine esters
DE870118C (en) Process for the preparation of salicyl-2-glucopyranose
DE686721C (en) Process for the preparation of hormone solutions
DE486198C (en) Process for the production of durable dosage forms from pancreatic preparations
AT107595B (en) Process for the preparation of 2-amino-3-nitropyridine-5-sulfonic acid.
DE575859C (en) Process for the preparation of salts of tertiary aliphatic bases
DE548437C (en) Method for preserving lecithin
DE464674C (en) Process for the preparation of products containing cholesterol which are colloidally soluble in an alkaline medium
AT164264B (en) Process for the manufacture of a liquid medicinal product for dermatological purposes
AT96997B (en) Process for the production of ethyl derivatives of cellulose or their conversion products.
AT234285B (en) Process for the preparation of cis-Δ <9> -heptadecenoic and cis-Δ <9> -pentadecenoic acid and their salts
DE728978C (en) Process for the preparation of durable suspensions of the anterior pituitary lobe hormones
DE472814C (en) Process for the production of vitamin-containing preparations
AT162118B (en) Method of making a remedy for rheumatic diseases.
DE755296C (en) Process for the production of a protracted preparation of the blood sugar lowering hormone
DE701956C (en) Process for obtaining hormone-like substances
DE588046C (en) Method for the separation of the oestrus hormone from urine
CH379489A (en) Process for the preparation of anti-inflammatory salts of cis-9-heptadecenoic and cis-9-pentadecenoic acid